Nilotinib is a potent, selective tyrosine kinase inhibitor (TKI) and a targeted antineoplastic agent used primarily to treat Philadelphia chromosome-positive chronic myeloid leukemia (CML).
Generic Name:
Nilotinib Hydrochloride
Indication:
For:
A cancer chemotherapy medication used to treat certain specific types of Chronic Myeloid Leukemia (CML)with a special genetic mutation and other types of CML that have not responded well to other cancer medications.
Supplied as:
Capsule Solution:
150mg , 200mg (60’s,112’s , 120’s)
Disclaimer:
Please consult your doctor before taking any medicine. To be sold only on prescription.